Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription


1 Am J Surg
4 BMC Cancer
1 BMC Surg
1 Cancer
1 Cancer Res
3 Dis Esophagus
2 Head Neck
2 Int J Cancer
2 Int J Pediatr Otorhinolaryngol
1 J Clin Oncol
3 J Laryngol Otol
10 Laryngoscope
32 Oral Oncol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. HSIAO V, Hanlon BM, Robbins SE, Connor NP, et al
    Discovering domains important to health-related quality of life in differentiated thyroid cancer.
    Am J Surg. 2022;224:1176-1178.

    BMC Cancer

  2. HUNG CJ, Kang BH, Chang KM, Kang YY, et al
    Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy.
    BMC Cancer. 2022;22:1084.
    PubMed         Abstract available

  3. TANG CL, Tsai WC, Lee JY, Wang YK, et al
    Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes.
    BMC Cancer. 2022;22:1086.
    PubMed         Abstract available

  4. YURA M, Fukuda K, Matsuda S, Irino T, et al
    Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1064.
    PubMed         Abstract available

  5. KIM SI, Woo SR, Noh JK, Lee MK, et al
    Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:1077.
    PubMed         Abstract available

    BMC Surg

  6. MUSTAFA DH, Ahmed BS, Haweizy RM, Dewana AM, et al
    Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq.
    BMC Surg. 2022;22:364.
    PubMed         Abstract available


  7. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    PubMed         Abstract available

    Cancer Res

  8. LIU J, Liu ZX, Li JJ, Zeng ZL, et al
    The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1alpha signaling in esophageal cancer.
    Cancer Res. 2022 Oct 20. pii: 709866. doi: 10.1158/0008-5472.CAN-22-1922.
    PubMed         Abstract available

    Dis Esophagus

  9. ZHOU J, Xu J, Chen L, Hu J, et al
    McKeown esophagectomy: robot-assisted versus conventional minimally invasive technique-systematic review and meta-analysis.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

  10. THAM JC, Pournaras DJ, Alcocer B, Forbes R, et al
    Gut hormones profile after an Ivor Lewis gastro-esophagectomy and its relationship to delayed gastric emptying.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

  11. ODETOYINBO K, Bachman K, Worrell S, Gray K, et al
    Factors influencing quality of lymphadenectomy in minimally invasive esophagectomy: a US-based analysis.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

    Head Neck

  12. GALIVETI CR, Kuhnell D, Biesiada J, Zhang X, et al
    Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.
    Head Neck. 2022 Oct 22. doi: 10.1002/hed.27231.
    PubMed         Abstract available

  13. SYKES KJ, Gibbs H, Farrokhian N, Arthur A, et al
    POINT: Pilot randomized, controlled, preoperative intervention for nutrition trial in head and neck cancer.
    Head Neck. 2022 Oct 17. doi: 10.1002/hed.27220.
    PubMed         Abstract available

    Int J Cancer

  14. JIN Z, Pei S, Ouyang L, Zhang L, et al
    Thy-Wise: An interpretable machine learning model for the evaluation of thyroid nodules.
    Int J Cancer. 2022;151:2229-2243.
    PubMed         Abstract available

  15. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    PubMed         Abstract available

    Int J Pediatr Otorhinolaryngol

  16. ZBITOU A, Desandes E, Guissou S, Mallebranche C, et al
    Thyroid cancers in children and adolescents in France: Incidence, survival and clinical management over the 2000-2018 period.
    Int J Pediatr Otorhinolaryngol. 2022;162:111325.
    PubMed         Abstract available

  17. SHARMA RK, Patel S, Gallant JN, Esianor BI, et al
    Racial, ethnic, and socioeconomic disparities in the presentation and management of pediatric thyroid cancer.
    Int J Pediatr Otorhinolaryngol. 2022;162:111331.
    PubMed         Abstract available

    J Clin Oncol

  18. PATIL VM, Noronha V, Menon N, Rai R, et al
    Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
    J Clin Oncol. 2022 Oct 20:JCO2201015. doi: 10.1200/JCO.22.01015.
    PubMed         Abstract available

    J Laryngol Otol

  19. CASASAYAS M, Sansa A, Garcia-Lorenzo J, Venegas MDP, et al
    Pharyngocutaneous fistula in irradiated patients: systematic review and our experience.
    J Laryngol Otol. 2022;136:1027-1033.
    PubMed         Abstract available

  20. LAYTON T, Thomas R, Harris C, Holmes S, et al
    Clinical outcomes following pharyngolaryngectomy reconstruction: a 20-year single-centre study.
    J Laryngol Otol. 2022;136:1105-1112.
    PubMed         Abstract available

  21. FISHMAN J, Fisher E
    Endoscopic stapes surgery, advanced head and neck cancer following the coronavirus disease pandemic, and upper airway remodelling in obstructive sleep apnoea.
    J Laryngol Otol. 2022;136:1013.


  22. ASARKAR AA, Pang J, Mansour J, Nathan CO, et al
    What Role Does Thyroglobulin Washout Have in Follow-Up Algorithm of Differentiated Thyroid Cancer?
    Laryngoscope. 2022;132:2087-2088.

  23. SYAL A, Lott DG, Zhang N, Karle WE, et al
    Prognostic and Treatment Differences Between T1a and T1b Glottic Cancer.
    Laryngoscope. 2022;132:2187-2193.
    PubMed         Abstract available

  24. MANSOUR J, Asarkar A, Pang J, Nathan CO, et al
    What Is the Role of Adjuvant Radiotherapy in Head and Neck Melanoma in the Era of Systemic Therapy?
    Laryngoscope. 2022;132:2085-2086.

  25. ZIAI H, Dixon P, Berman G, Campisi P, et al
    Incidental Parathyroidectomy Among Pediatric Patients Undergoing Thyroid Surgery.
    Laryngoscope. 2022;132:2262-2269.
    PubMed         Abstract available

  26. HIRSHOREN N, Abd El Qadir N, Weinberger JM, Eliashar R, et al
    Sentinel Lymph Node Identification in Cutaneous Head & Neck Cancer - Lymphoscintigraphy Late Phase.
    Laryngoscope. 2022;132:2164-2168.
    PubMed         Abstract available

  27. BROOKS JA, Abdelhamid Ahmed AH, Al-Qurayshi Z, Kamani D, et al
    Recurrent Laryngeal Nerve Invasion by Thyroid Cancer: Laryngeal Function and Survival Outcomes.
    Laryngoscope. 2022;132:2285-2292.
    PubMed         Abstract available

  28. FITZGERALD CWR, Dogan S, Bou-Nassif R, Mclean T, et al
    Stimulated Raman Histology for Rapid Intra-Operative Diagnosis of Sinonasal and Skull Base Tumors.
    Laryngoscope. 2022;132:2142-2147.
    PubMed         Abstract available

  29. TSUNODA K, Nagai R, Kobayashi R, Takazawa M, et al
    Tone Enhancement Electro-Fiberscope Combined with Strobe Light Source and Re-analysis Past Images-Tone Enhancement Dynamic Stroboscope.
    Laryngoscope. 2022;132:2206-2208.
    PubMed         Abstract available

  30. SNYDER V, Gooding W, Sridharan S
    In Response to PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Laryngoscope. 2022;132:E38.

  31. LI M, Zhang C, Yu T
    In Reference to PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Laryngoscope. 2022;132:E37.

    Oral Oncol

  32. DE LUCA P, Scarpa A, Viola P, Motta G, et al
    Collision tumors of the larynx: A retrospective single-center case series of an extremely rare phenomenon.
    Oral Oncol. 2022;134:106096.

  33. TOPKAN E, Somay E, Yilmaz B, Kucuk A, et al
    Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
    Oral Oncol. 2022;134:106098.

  34. KAJO K, Othman BK, Kajova Machalekova K
    Sclerosing Warthin-like mucoepidermoid carcinoma of the salivary gland.
    Oral Oncol. 2022;134:106090.

  35. SEKARAN S, Ganapathy D
    Salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders.
    Oral Oncol. 2022;134:106065.

  36. FESTA BM, Costantino A, Ferreli F, Spriano G, et al
    The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores: Avoiding the wrong conclusion.
    Oral Oncol. 2022;134:106071.

  37. WEINBERGER JM, Abd El Qadir N, Hirshoren N
    Double trouble: A cohort study of re-irradiation and laryngectomy - Severity of and risk for pharyngocutaneous fistula.
    Oral Oncol. 2022;134:106069.
    PubMed         Abstract available

  38. DE BREE R, Leemans CR
    When to perform a paratracheal lymph node dissection during total laryngectomy?
    Oral Oncol. 2022;134:106048.

  39. OLAWUNI FO, Sauer AB, Daher GS, Douse DM, et al
    The reporting and representation of sex and gender in head and neck cancer clinical trials.
    Oral Oncol. 2022;135:106217.

  40. SUNDRAMOORTHY AK, Atchudan R, Arya S
    Utilization of Raman spectroscopy in biochemical fingerprint analysis for oral cancer screening and diagnosis.
    Oral Oncol. 2022;135:106192.

  41. ZHU L, Deng Y, Ji T, Zhou H, et al
    Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
    Oral Oncol. 2022;135:106196.

  42. MANJUSHA M, Saravanan M
    Development of novel electrochemical based nano-biosensors for the diagnosis of oral potentially malignant disorders and oral carcinoma.
    Oral Oncol. 2022;135:106197.

  43. SEKAR AA, Veeraraghavan VP, Raj AT, Patil S, et al
    Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer.
    Oral Oncol. 2022;135:106195.

  44. GURMEET SINGH A, Sathe P, Roy S, Thiagrajan S, et al
    Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth?
    Oral Oncol. 2022;135:106201.
    PubMed         Abstract available

  45. KRISHNAMOORTHY K, Priya Veeraraghavan V, Jayaraman S
    E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;135:106193.

  46. MORSE RT, Beaty B, Scanga L, Blumberg J, et al
    Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;134:106131.
    PubMed         Abstract available

  47. ERRAZQUIN R, Page A, Sunol A, Segrelles C, et al
    Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
    Oral Oncol. 2022;134:106184.
    PubMed         Abstract available

  48. CHIDAMBARAM S, Hong SA, Simpson MC, Osazuwa-Peters N, et al
    Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
    Oral Oncol. 2022;134:106132.
    PubMed         Abstract available

  49. AROSIO AD, Bernasconi DP, Valsecchi MG, Pacifico C, et al
    Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers.
    Oral Oncol. 2022;134:106123.
    PubMed         Abstract available

  50. CONTRERA KJ, Zafereo ME, Yaniv D, Roberts DB, et al
    Outcomes for recurrent oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;134:106127.
    PubMed         Abstract available

  51. DAS R, Misra SR, Pradhan S
    A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!
    Oral Oncol. 2022;134:106126.

  52. LIU Y, Bilodeau E, Pollack B, Batmanghelich K, et al
    Automated detection of premalignant oral lesions on whole slide images using convolutional neural networks.
    Oral Oncol. 2022;134:106109.
    PubMed         Abstract available

  53. TITINCHI F, Sallies M, Wu HT
    Mucoepidermoid carcinoma ex pleomorphic adenoma: A rare diagnostically challenging entity.
    Oral Oncol. 2022;134:106112.
    PubMed         Abstract available

  54. RAMASUBBU K, Devi Rajeswari V
    A novel target approach for epithelial-mesenchymal transitioning oral squamous cell carcinoma and their involvement of PI3K/Akt/mTOR and Hedgehog signaling pathway.
    Oral Oncol. 2022;134:106119.

  55. VILLEGAS KM, Paparella ML
    Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature.
    Oral Oncol. 2022;134:106068.
    PubMed         Abstract available

  56. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
    Oral Oncol. 2022;134:106120.

  57. CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
    MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;134:106124.

  58. YASASVE M, Saravanan M
    Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma.
    Oral Oncol. 2022;134:106104.

  59. ROH JL
    Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland.
    Oral Oncol. 2022;134:106103.
    PubMed         Abstract available

  60. SEKAR D, Selvakumar SC, Auxzilia Preethi K
    Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
    Oral Oncol. 2022;134:106106.

  61. ELUMALAI P, Ezhilarasan D
    Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.
    Oral Oncol. 2022;134:106100.

  62. MANJUSHA M, Saravanan M
    Oropharyngeal cancer associated with sarcopenic obesity and sarcopenic weight loss.
    Oral Oncol. 2022;134:106101.

  63. FITZGERALD CWR, Davies JC, de Almeida JR, Rich JT, et al
    Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study.
    Oral Oncol. 2022;134:106089.
    PubMed         Abstract available

    PLoS One

  64. CHANG YL, Cheng YF, Chen HS, Wu SC, et al
    Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0271338.
    PubMed         Abstract available

  65. CABUZU D, Ramakrishnan SK, Moor MB, Harmacek D, et al
    Loss of Ecrg4 improves calcium oxalate nephropathy.
    PLoS One. 2022;17:e0275972.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.